Sarepta Therapeutics H-1B salaries
How much does Sarepta Therapeutics, Inc. pay H-1B workers?
Sarepta Therapeutics, Inc.'s certified H-1B LCAs in FY2024–FY2026 (49 applications) offered a median of $126k a year. Most-filed titles: Senior Engineer, Gene Therapy Upstream Process Development $104k, Senior Manager, CMC Regulatory Affairs $155k and Scientist II, Discovery Chemistry $121k. These are wages the employer attested to the U.S. Department of Labor, not offers to you.
Sarepta Therapeutics, Inc. sponsorship record →2 open jobs →
- median wage offered
- $126k
- certified LCAs, FY24–26
- 49
- job titles with wages
- 40
By job title
| Job title on the LCA | LCAs | Median wage |
|---|---|---|
| Senior Engineer, Gene Therapy Upstream Process Development | 3 | $104k |
| Senior Manager, CMC Regulatory Affairs | 3 | $155k |
| Scientist II, Discovery Chemistry | 3 | $121k |
| Associate Director, Statistical Programming | 2 | $179k |
| Senior Manager, Social Media Engagement | 2 | $154k |
| Principal Engineer, Manufacturing Sciences and Technology | 2 | $159k |
| Associate Director, Global Pharmacovigilance Operations | 1 | $170k |
| Associate Director, IT Validation | 1 | $177k |
| Senior Associate, Gene Therapy Quality Control | 1 | $99k |
| Senior Associate, rcAAV | 1 | $99k |
| Data Analytics Lead Engineer | 1 | $126k |
| Dir., Quantitative Clinical Pharma: PK/PD Modeling & Strtgy | 1 | $230k |
| Director, CMC Procurement | 1 | $202k |
| Director, Quality Control | 1 | $191k |
| Director, Regulatory Affairs CMC | 1 | $197k |
| Director, Safety Scientist | 1 | $192k |
| Senior Engineer, QA Validation and Engineering | 1 | $103k |
| Engineer, RNA Drug Substance Manufacturing | 1 | $85k |
| Executive Dir., Gene Therapy Commercialization Capabilities | 1 | $279k |
| Lead Engineer, QA IT Validation | 1 | $120k |
| Senior Manager, Drug Product Manufacturing Science & Tech. | 1 | $155k |
| Senior Manager, Supply Chain Planning and Analytics | 1 | $148k |
| Sr. Mgr, Capital Projects (Mechanical Engineer & HVAC) | 1 | $148k |
| Principal Scientist, Analytical Development | 1 | $157k |
| Principal Statistical Analyst | 1 | $149k |
| Principal Statistical Programmer | 1 | $149k |
| Project Manager, Scientific Business Development | 1 | $126k |
| QC Analyst | 1 | $92k |
| Quality Control Associate II “ Physical Titer | 1 | $85k |
| Quality Control Associate II, Potency | 1 | $85k |
| Quality Control Investigations Manager | 1 | $126k |
| Senior Research Associate | 1 | $107k |
| Research Associate, Gene Therapy | 1 | $72k |
| Research Associate II, Gene Therapy Analytical Development | 1 | $83k |
| Research Associate II, In Process Analytics | 1 | $76k |
| Senior Research Associate, Translational Biology | 1 | $90k |
| Scientist, Bioinformatics | 1 | $108k |
| Scientist II, Drug Product Development | 1 | $126k |
| Scientist I, Early Stage Process Development, Gene Therapy | 1 | $102k |
| Scientist I, Quality Control | 1 | $112k |
By occupation and state
Middle half (25th–75th percentile) of wages offered, the median prevailing wage on the same LCAs, and how the median compares with every H-1B employer's median for that occupation in that state.
| Occupation (SOC) | State | LCAs | Wage range (p25–p75) | Median | Prevailing wage | vs market |
|---|---|---|---|---|---|---|
| Medical Scientists, Except Epidemiologists 19-1042 | Massachusetts | 22 | $104k–$155k | $124k | $106k | +45% |
| Molecular and Cellular Biologists 19-1029 | Massachusetts | 4 | $108k–$126k | $117k | $99k | +35% |
| Marketing Managers 11-2021 | Massachusetts | 3 | $160k–$279k | $160k | $147k | -5% |
| Industrial Engineers 17-2112 | Massachusetts | 3 | $103k–$148k | $103k | $98k | -6% |
| Industrial Production Managers 11-3051 | Massachusetts | 2 | $126k–$191k | $159k | $129k | +6% |
| Regulatory Affairs Managers 11-9199 | Massachusetts | 2 | $155k–$197k | $176k | $160k | -4% |
| Biological Technicians 19-4021 | Massachusetts | 2 | $76k–$90k | $83k | $66k | +28% |
| Computer and Information Systems Managers 11-3021 | Massachusetts | 1 | $177k–$177k | $177k | $177k | -7% |
| Purchasing Managers 11-3061 | Massachusetts | 1 | $202k–$202k | $202k | $196k | +36% |
| Computer Systems Analysts 15-1211 | Massachusetts | 1 | $179k–$179k | $179k | $142k | +56% |
| Software Quality Assurance Analysts and Testers 15-1253 | Texas | 1 | $120k–$120k | $120k | $94k | +25% |
| Statisticians 15-2041 | North Carolina | 1 | $149k–$149k | $149k | $148k | +18% |
| Data Scientists 15-2051 | Massachusetts | 1 | $179k–$179k | $179k | $149k | +45% |
| Mechanical Engineers 17-2141 | Massachusetts | 1 | $148k–$148k | $148k | $135k | +40% |
| Biochemists and Biophysicists 19-1021 | Massachusetts | 1 | $107k–$107k | $107k | $107k | +12% |
| Medical Scientists, Except Epidemiologists 19-1042 | North Carolina | 1 | $72k–$72k | $72k | $63k | +1% |
| Medical Scientists, Except Epidemiologists 19-1042 | Ohio | 1 | $102k–$102k | $102k | $95k | +53% |
| Chemists 19-2031 | Massachusetts | 1 | $157k–$157k | $157k | $141k | +37% |
Sarepta Therapeutics, Inc. H-1B salary questions
How much does Sarepta Therapeutics, Inc. pay H-1B workers?
Sarepta Therapeutics, Inc.'s certified H-1B LCAs in FY2024–FY2026 (49 applications) offered a median of $126k a year. Most-filed titles: Senior Engineer, Gene Therapy Upstream Process Development $104k, Senior Manager, CMC Regulatory Affairs $155k and Scientist II, Discovery Chemistry $121k. These are wages the employer attested to the U.S. Department of Labor, not offers to you.
What does Sarepta Therapeutics, Inc. pay Medical Scientists, Except Epidemiologists on H-1B in Massachusetts?
On 22 certified LCAs (FY2024–FY2026) the middle half of offered wages ran $104k–$155k, median $124k, against a median prevailing wage of $106k on the same applications.
Are H-1B salaries public?
Yes. Employers must state the offered wage on each Labor Condition Application, and the U.S. Department of Labor publishes certified LCAs in its quarterly disclosure files. These figures come from those files.
Does the H-1B salary include bonus or stock?
No. The LCA wage is the base wage the employer attests to; bonuses, stock and benefits are not part of it, so total pay is often higher.